Influenza virus hemagglutinin stalk-based antibodies and vaccines
- 23 August 2013
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Virology
- Vol. 3 (5), 521-530
- https://doi.org/10.1016/j.coviro.2013.07.007
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesProceedings of the National Academy of Sciences, 2013
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cellsProceedings of the National Academy of Sciences, 2012
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 virusesProceedings of the National Academy of Sciences, 2012
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A VirusesScience, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionThe Journal of Experimental Medicine, 2011
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences, 2010
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by VaccinationScience, 2010
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeProceedings of the National Academy of Sciences, 2010
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008